Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Natural Ophthalmics is a private U.S. eye-care company that markets commercial natural and homeopathic ophthalmic products, primarily eye drops and related formulations for dry eye, allergy, cataracts, floaters, and contact lens or orthokeratology use. The business appears to operate under the legal entity Natural Ophthalmics, Inc. and has been associated with Colorado addresses including Lafayette and Dillon. Its products are sold as branded over-the-counter or practitioner-dispensed eye-care products rather than as a traditional clinical-stage biotech pipeline. The company is healthcare-related, but it does not appear to be a biotechnology drug developer with disclosed molecular targets or a conventional R&D pipeline. FDA issued a warning letter to the company in September 2023 regarding several ophthalmic products marketed in the United States as unapproved new drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Natural Ophthalmics.